IL17A and neurodegenerative disease: Studies have pointed out that inhibition of OPA1 enhances the progression of neurodegenerative diseases, and OPA-1 regulates apoptosis resistance of OXPHOS IL-17-producing CD4 T cells by regulating mitochondrial fusion and limiting mitophagy [73].